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Background: Heterozygous carriers of lecithin:cholesterol acyltransferase (LCAT) gene mutations have very low plasma levels of high density 
lipoprotein cholesterol (HDL-c). However, data on atherogenesis in carriers of LCAT mutations have yielded unequivocal Results:  Therefore, we 
assessed the atherosclerotic disease state in a large group of LCAT carriers compared to matched controls.
Methods: 3.0 Tesla MRI scans were made of the carotid arteries of 41 heterozygous carriers of LCAT mutations (aged 43, SD 14 years) and 
54 unaffected controls (aged 41, SD 15 years) matched for age and gender. Participants referred to the clinic with cardiovascular disease were 
excluded. Axial T1-weighted TSE images were acquired. Sequence parameters were: slice thickness 3mm, non-interpolated pixel size 0.25 x 0.25mm, 
TE 11ms and a heart rate triggered TR, active fat suppression (SPAIR) and a double inversion black blood prepulse. Carotid Mean Wall Area (MWA, 
mm2) and Normalized Wall Index (NWI), defined as the ratio between the wall and outer wall area, were quantified.
Results: In the carriers, MWA was 18.2 (SD 0.9) mm2, versus 14.2 (SD 0.4) mm2 in controls (p=0.01), NWI was 0.34 (SD 0.07) versus 0.31 
(SD 0.05, p=0.01). In a multivariate analysis the heterozygosity for an LCAT mutation was a predictor of MWA (p=0.003) and NWI (p=0.007), 
independent of age, sex and low-density lipoprotein cholesterol (LDL-c). Lipid levels in the carriers and controls were: Total cholesterol 4.7 (SD 4.6) 
versus 4.6 (SD 1.2) mmol/l (p=0.61), LDL-c 3.1 (SD 1.0) versus 2.8 (SD 1.0) mmol/l (p=0.11), HDL-c 0.8 (SD 0.3) versus 1.5 (SD 0.4) mmol/l 
(p<0.001), triglycerides 1.8 (SD 1.7) versus 1.1 (SD 1.3) mmol/l (p=0.02).
Conclusion: In heterozygous carriers of LCAT mutations low HDLc levels coincide with increased vessel wall thickness of the carotid arteries, 
indicative of increased cardiovascular disease risk. These findings indicate that LCAT activity is pivotal for atheroprotection.
